M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH).

Roumier, Christophe

M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH). [electronic resource] - Blood Feb 2003 - 1277-83 p. digital

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

0006-4971

10.1182/blood-2002-05-1474 doi


Adult
Aged
Aged, 80 and over
Bone Marrow--pathology
Core Binding Factor Alpha 2 Subunit
DNA-Binding Proteins--genetics
Gene Rearrangement, T-Lymphocyte
Humans
Immunoglobulin Heavy Chains--genetics
Immunophenotyping
In Situ Hybridization, Fluorescence
Leukemia, Myeloid, Acute--genetics
Leukocyte Count
Middle Aged
Point Mutation
Prognosis
Proto-Oncogene Proteins--genetics
Receptor Protein-Tyrosine Kinases--genetics
Receptors, Antigen, T-Cell--genetics
Retrospective Studies
Survival Rate
Transcription Factors--genetics
fms-Like Tyrosine Kinase 3